Jaiwant Rangi, MD, FACEEndocrinologist | Founder, Lower The Dose® | Speaker

Beyond Blood Sugar: The Paradigm Shift in Modern Diabetes Management

2 Aug 2026 · 1 min

Watch on YouTube

0:37

Dr. Jaiwant Rangi explains why doctors now prescribe SGLT2 inhibitors and GLP-1 receptor agonists to protect kidneys and hearts, even when blood sugar is already controlled. The shift moves away from chasing A1C numbers toward preventing organ damage.

Chapters

And here's what the latest guidelines show now. Use the protective medications even if the A1C is already at target. Let me repeat that. The new guidelines recommend that use the protective medications even if the A1C is already at target. That tells you this works above and beyond just the blood sugars. The organ protection is the reason, not just the sugar lowering. And that is a fundamental shift in diabetes care. Protect the organ and good sugar control comes along for a ride. Chase only the sugar and you can lose the organ.